US FDA approves Ultragenyx's gene therapy for rare disorder
RARE•FDA approves Ultragenyx gene therapy
The U.S. Food and Drug Administration said on Thursday it has approved Ultragenyx's gene therapy for the treatment of a rare, fatal disease.
RARE•The U.S. Food and Drug Administration said on Thursday it has approved Ultragenyx's gene therapy for the treatment of a rare, fatal disease.
